Zhenoluten
Khavinson natural peptide complex derived from ovarian tissue — studied for female reproductive health, menopausal symptom management, and ovarian function support.
🔬 Mechanism of Action
Zhenoluten is a Khavinson Cytomax derived from ovarian tissue, the female reproductive counterpart to Testoluten (testicular Cytomax). It contains ovarian-specific peptides regulating gene expression in granulosa cells, theca cells, and ovarian stroma.
Zhenoluten modulates: (1) aromatase (CYP19A1) expression in granulosa cells for estradiol synthesis, (2) FSH and LH receptor sensitivity on granulosa and theca cells, (3) anti-Mullerian hormone (AMH) production — a marker of ovarian reserve, and (4) progesterone synthesis enzymes in the corpus luteum.
In Khavinson female health protocols, Zhenoluten is used for early perimenopause support, age-related fertility optimization, and post-hormonal therapy ovarian rehabilitation.
Source: PMID: 15677927
📜Background & History
Zhenoluten is the ovarian Cytomax extract, supporting female reproductive health and hormonal balance.
🎯 Research Use Cases
- ✓Female reproductive health
- ✓Menopausal support
- ✓Ovarian function maintenance
💉 Dosing Protocol
| Typical Dose | 1-2 capsules/day |
| Frequency | 1-2× daily for 10-30 day cycles |
| Half-Life | ~30 minutes (estimated) |
⚠️Safety & Considerations
Standard oral Cytomax capsule protocol. Consult gynecologist if existing hormonal conditions or hormone-sensitive conditions.
⚡Interactions & Contraindications
Consult gynecologist if hormone-sensitive conditions.